Geneva, 31 July 2015 - Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of in…
Read more23 July 2015, Geneva -On World Hepatitis Day (28 July) WHO highlights the urgent need for countries to enhance action to prevent viral hepatitis infection and to ensure that people who have been infected are diagnos…
Read moreBrazzaville, 27 July 2015 – Dr Matshidiso Moeti, the World Health Organization (WHO) Regional Director for Africa, Dr Chris Elias, President of the Global Development Division of the Bill & Melinda Gates Foundation, …
Read moreThe ongoing Ebola outbreak clearly demonstrates how the inability to prevent, detect, and control a threat in one part of the world poses a threat to everyone, everywhere. It has the potential to cause enormous damage in…
Read moreYaoundé, 23 July 2015 – The World Health Organization (WHO) African Region continues to be challenged by frequent natural and man-made emergencies as well as large-scale disease outbreaks that cause injuries, deaths…
Read moreBrazzaville, 21 July 2015 - A high level delegation from the Bill & Melinda Gates Foundation (BMGF) has begun a four-day official visit to the World Health Organization Regional Office for Africa (AFRO) in Brazz…
Read moreLuanda, 17 July 2015 – The hepatitis B virus vaccine has been introduced into the Expanded Programme of Immunization (EPI) of Angola on 14th July 2015 as part of the joint efforts developed by the Government a…
Read moreBrazzaville, 16 July 2015 – A high level delegation from Merck, a drug pharmaceutical company donating Praziquantel (PZQ) tablets for schistosomiasis control and elimination, has today paid a courtesy call to the Wo…
Read more